Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel with or without RAD001 (everolimus) in advanced gastric cancer after fluoropyrimidine/platinum
2009-018092-14Phase 3Completed
- Sponsor
- Krankenhaus Nordwest
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma comparing Paclitaxel + RAD001 (everolimus) with Paclitaxel + placebo (2 arms). Primary endpoint: Overall survival. Started Apr 2011; status: completed.
02
Drugs
everolimus
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on 2009-018092-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018092-14.